IFM AIC 2026 · Conference Exclusive

Fatty liver is the door.
Cardiometabolic health
is the house.

Your patients already have a fatty liver problem. Now you have a program for it.

MLR-90 is a complete 90-day cardiometabolic reset grounded in peer-reviewed clinical science — designed for full cardiometabolic assessment with the clinical tools to act on what you find.

Vascular
Hepatic
Metabolic
  • Two CMiQ cardiometabolic panels — baseline and 90-day retest
  • BergaPure supplementation — 90-day supply, RCT-validated protocol
  • Complete patient and practitioner guidance — written assets, education materials, and video content, pre-built and ready to deploy

Conference pricing: $249  ·  TMiQ thyroid upgrade available +$40

Get Started (CMIQ) → $249 Get Started (TMIQ) → $289 Try a Free CMiQ Report →
MLR-90 program kit — CMiQ panel box and BergaPure 90-day supply
The Clinical Reality

The most consequential metabolic condition
in your practice is the one
you may not be seeing.

Metabolic Associated Steatotic Liver Disease — MASLD — affects an estimated 80 million Americans. The majority have no idea. Neither do their practitioners. Not because they aren’t looking. Because the standard tools don’t show it until significant damage has already occurred.

80M+
Americans with undetected fatty liver disease
Issa et al., Journal of Hepatology, 2025 · DOI: 10.1016/j.jhep.2025.03.001
+85%
Increased all-cause mortality risk in patients with documented MASLD vs. matched general population controls
Issa et al., Journal of Hepatology, 2025 · DOI: 10.1016/j.jhep.2025.03.001
+61%
Increased risk of heart attack, stroke, and cardiovascular death at Fatty Liver Index ≥60 — even when conventional labs appear normal
Zhong et al., Am J Preventive Cardiology, 2026 · PMID: 41624044

This isn’t a rare finding at the margins of your practice. It’s sitting in your existing patient population right now — unidentified, unaddressed, and driving cardiometabolic outcomes that conventional assessment simply wasn’t designed to catch.

The Protocol

A validated, repeatable clinical program.
Built to run. Built to scale.

MLR-90 is structured around a single clinical logic: test what’s there, address it with a validated protocol, and reassess to confirm what changed. Applied consistently, delivered turnkey — clinically rigorous and practically deployable in any FM practice.

01
Phase One

Test

Baseline CMiQ cardiometabolic panel — full physiologic strain assessment including hepatic, vascular and metabolic markers. DBS kit shipped directly to patient.

02
Phase Two

Address

90-day BergaPure protocol — one capsule daily, 600mg, matching the active dose from Ferro et al. 2020 RCT. Paired with structured lifestyle guidance: three to four 30-minute walks per week and modest dietary efforts toward healthy Mediterranean-style foods with a 400–500 calorie daily reduction. Straightforward enough to sustain for 90 days, evidence-based enough to move the markers. Supported by pre-built patient education assets and check-in video content throughout.

03
Phase Three

Reassess

90-day retest CMiQ panel — same comprehensive assessment, now measuring change. PSM-powered comparison report shows practitioners and patients exactly what moved and why it matters.

Practice Efficiency

MLR-90 is designed for individual patients and group cohorts of 4–6. Running a cohort multiplies your revenue per clinical hour without adding complexity. The program infrastructure handles patient education and check-ins — your role is the results review.

Every clinical asset, education material, and video is pre-built and included. The one thing not included is the consultation — because that’s where your expertise lives.

Already Running Cardiometabolic Panels?

Anybody can buy eggs and butter.
Not everybody can make a soufflé.

The markers in a CMiQ panel are available through standard reference labs. But raw ingredients aren’t a meal. A Labcorp or Quest cardiometabolic panel returns a column of numbers against population reference ranges. It answers one question: is this patient a statistical outlier?

CMiQHealth’s Physiologic Strain Model answers a different question entirely: how much biological stress is this patient’s cardiometabolic system actually under — and where is it coming from? The PSM report is organized by physiologic domain, scored for strain severity, and structured to walk through with a patient in 20–30 minutes. No hopping between report pages to construct a narrative while your patient’s eyes glaze over. The clinical intelligence is built in.

And one marker you won’t find on any standard reference lab panel: Fatty Liver Index — the most consequential cardiometabolic risk marker that no other commercial DBS panel reports.

The Opportunity

A high-margin program.
Built around an hour of your time.

Two 20–30 minute practitioner-guided consultations per patient — one after baseline results, one after the 90-day retest. The program handles everything in between.

Your Program Cost
$249
Conference rate per patient seat
Two CMiQ panels, BergaPure 90-day supply, all program assets included
Patient Program Price
$699–799
Suggested retail — your pricing decision
Your Margin
$450–550
Per patient, per hour of clinical time
The Cohort Advantage

Run four patients. Change the math entirely.

MLR-90 is group cohort friendly by design. Four patients sharing the same program cycle means four times the revenue on approximately the same time investment. At $749 average patient price, a single cohort of four generates nearly $3,000 in new program revenue.

$2,996
4 patients × $749
2–4 hrs
Your time investment
$750–$1,500
Revenue per clinical hour

*Group/individual consult format at practitioner discretion.

Between consultations, check-in frequency and format are practitioner-determined — group email, video call, or in-office. Two to four check-ins over the 90-day period is suggested. Pre-built video content and structured patient guidance support engagement throughout.
Secondary outcome — Ferro et al. RCT: BergaPure patients lost 56% more weight than placebo over 12 weeks (4.2 kg vs. 2.7 kg, p=0.004) — the kind of visible result that drives patient satisfaction, retention, and referrals.

Your patients get a clinically rigorous 90-day reset. You get a program designed to run without you in the room.

The Clinical Foundation

Every protocol element.
Peer-reviewed and published.

MLR-90 is not built on clinical consensus or wellness trends. Every element — the assessment markers, the supplementation protocol, and the cardiometabolic risk framework — is anchored to published, peer-reviewed clinical data. These are the four studies that matter most.

76%
Of patients taking BergaPure showed measurable improvement in liver fat grade over 12 weeks — compared to 51% in the placebo group.
A double-blind RCT in 102 confirmed hepatic steatosis patients. BergaPure reduced liver fat, LDL-C, HOMA-IR, AST and GGT. Placebo did not.
Ferro et al., Frontiers in Endocrinology, 2020 · PMID: 32849284
Confirmed
BergaPure significantly improved vascular inflammation and oxidative stress markers in patients with both T2DM and MASLD — a population at compounded cardiometabolic risk.
Extends the Ferro findings to the diabetic MASLD population. Validates BergaPure’s mechanism beyond liver fat reduction to broader cardiometabolic benefit.
Musolino et al., Journal of Traditional and Complementary Medicine, 2020 · PMID: 32670822
+85%
Increased all-cause mortality risk in patients with documented MASLD compared to matched general population controls.
Population-based study of 13,099 Swedish MASLD patients. Cardiovascular disease and non-HCC cancer were the highest absolute causes of death — not liver disease. MASLD is a systemic cardiometabolic condition, not a liver-isolated one.
Issa et al., Journal of Hepatology, 2025 · DOI: 10.1016/j.jhep.2025.03.001
+61%
Increased risk of heart attack, stroke, and cardiovascular death at Fatty Liver Index ≥60 — even when conventional cardiometabolic labs appear normal.
52-study meta-analysis confirming FLI and TyG Index as independent predictors of major adverse cardiovascular events. A patient can look completely normal on standard labs and carry a 61% elevated risk of heart attack, stroke, or cardiovascular death. Both markers are standard in every CMiQ panel.
Zhong et al., American Journal of Preventive Cardiology, 2026 · PMID: 41624044

The science existed. The clinical tool to act on it didn’t. Now it does.

What’s Included

Everything pre-built.
Nothing left to create.

Every clinical asset, patient education material, and video content piece is included in the MLR-90 program seat. Designed so that a practitioner with no prior experience running a structured metabolic protocol can deploy it confidently from day one.

Lab Panels
  • Baseline CMiQ cardiometabolic panel — DBS kit shipped directly to patient
  • 90-day retest CMiQ panel — shipped directly to patient
  • PSM-powered Physiologic Strain Report for both draws
  • Full vascular, hepatic and metabolic marker assessment including FLI, TyG, ApoB, Lp(a), hs-CRP and GGT
  • TMiQ thyroid panel upgrade available — +$40 per seat
CardioMetaboliQ Panel and Report kit
Supplementation
  • 3 bottles BergaPure — 90-day supply
  • One capsule daily — designed for real-world patient compliance
  • 600mg per capsule — matches active dose from Ferro et al. 2020 RCT
  • 92% adherence rate in clinical trial
  • DolCas Biotech Bergacyn formulation
  • Placebo-equivalent safety profile
BergaPure patented liver formula bottle
Practitioner & Patient Guidance
  • MLR-90 Practitioner Guide — clinical scripting and delivery framework
  • Patient Program Guide — week-by-week phase map
  • 90-Day Tracker — fillable, with retest prompt at day 85
  • Metabolic SmartSwaps Guide — patient and practitioner versions
  • Structured, simple and safe lifestyle guidance — pre-built and patient-ready
Video Content
  • Patient intro video — program overview and what to expect
  • Week 4 and Week 8 check-in videos — FAQ and motivation content
  • Retest preparation video — finish line framing
  • All scripts provided if practitioner prefers to record personal versions
Every asset in this program is designed to make MLR-90 fully functional with minimal practitioner involvement — two practitioner-guided results review consultations and the program runs itself. The tools are there for a standalone, systemized deployment. That said, some practitioners will choose greater patient contact based on their practice style and patient relationships. MLR-90 accommodates both. You decide how much of yourself you bring to the program.
IFM AIC 2026 · Conference Pricing

Everything you need to launch.
At the best price we offer.

This pricing is available to IFM AIC 2026 attendees. The MLR-90 conference seat includes everything covered on this page — no additional purchases required to run your first patient or cohort.

MLR-90 Conference Seat
$249
Two CMiQ panels ($498 retail value) · BergaPure 90-day supply · Complete program asset suite
Everything included. Nothing additional required to run your first patient.
TMiQ thyroid panel upgrade available — +$40 per seat
01

Purchase Your Seat

Click Get Started, complete checkout, and attest that ordering laboratory testing falls within your scope of practice as a licensed healthcare practitioner.

03

Launch Your First Patient

Your complete MLR-90 program kit is ready to deploy. Order your first patient DBS kit, schedule your baseline results review, and start finding hidden risk.

Once credential verification is complete, your CMiQHealth practitioner account provides access to additional MLR-90 seats, our full cardiometabolic panel suite, BergaPure capsules at wholesale pricing, and OnDemand Report Generation — all available directly in our store.
Many patients choose to continue the MLR protocol beyond 90 days for ongoing cardiometabolic support, with CMiQ retesting every 6–12 months to track and maintain their gains. Wholesale BergaPure pricing and CMiQ panels are available directly in your practitioner store — making long-term patient maintenance simple and profitable.

Not ready to purchase today? Generate a complimentary OnDemand CMiQ report using your NPI number and experience the platform firsthand.

Try a Free CMiQ Report →

Your patients are ready.
Are you?

Start finding hidden cardiometabolic risk in your practice today.

MLR-90 conference seat — $249. Everything included.

Get Started (CMIQ) → $249 Get Started (TMIQ) → $289 Try a Free CMiQ Report →

Questions? support@cmiqhealth.com